New Twice-Yearly Inclisiran Therapy Shows Major Reduction in LDL Cholesterol - Medscape

New Twice-Yearly Inclisiran Therapy Shows Major Reduction in LDL Cholesterol - Medscape
Health

Listen to this article

0%

A novel lipid-lowering therapy, administered twice yearly, showed a significant reduction of elevated low-density lipoprotein cholesterol (LDL-C), a key modifiable risk factor for atherosclerotic car… [+5320 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected